Ocular Therapeutix, Inc. (OCUL)
10.78
-0.30
(-2.71%)
USD |
NASDAQ |
Aug 24, 16:00
10.73
-0.05
(-0.46%)
After-Hours: 07:58
Ocular Therapeutix Price : 10.78 for Aug. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 24, 2026 | 11.03 | 11.05 | 10.61 | 10.78 | 2.358M |
| Aug 21, 2026 | 11.10 | 11.49 | 10.94 | 11.08 | 3.051M |
| Aug 20, 2026 | 11.52 | 11.62 | 11.07 | 11.09 | 3.295M |
| Aug 19, 2026 | 11.29 | 11.74 | 11.18 | 11.73 | 3.024M |
| Aug 18, 2026 | 10.50 | 11.22 | 10.30 | 11.01 | 4.583M |
| Aug 17, 2026 | 10.80 | 11.20 | 10.50 | 10.65 | 11.15M |
| Aug 14, 2026 | 10.04 | 10.07 | 9.68 | 10.04 | 1.634M |
| Aug 13, 2026 | 10.27 | 10.43 | 10.08 | 10.10 | 2.585M |
| Aug 12, 2026 | 9.77 | 10.43 | 9.74 | 10.23 | 4.006M |
| Aug 11, 2026 | 9.29 | 9.77 | 9.16 | 9.76 | 2.180M |
| Aug 10, 2026 | 9.20 | 9.305 | 9.04 | 9.24 | 1.530M |
| Aug 07, 2026 | 8.80 | 9.20 | 8.80 | 9.19 | 2.017M |
| Aug 06, 2026 | 8.45 | 8.79 | 8.40 | 8.74 | 1.594M |
| Aug 05, 2026 | 8.68 | 8.79 | 8.45 | 8.50 | 1.600M |
| Aug 04, 2026 | 8.40 | 8.715 | 8.355 | 8.59 | 2.232M |
| Aug 03, 2026 | 8.285 | 8.495 | 8.175 | 8.40 | 3.327M |
| Jul 31, 2026 | 8.44 | 8.564 | 8.15 | 8.17 | 2.152M |
| Jul 30, 2026 | 8.37 | 8.53 | 8.27 | 8.47 | 2.686M |
| Jul 29, 2026 | 8.51 | 8.61 | 8.295 | 8.36 | 1.785M |
| Jul 28, 2026 | 8.61 | 8.665 | 8.305 | 8.45 | 2.373M |
| Jul 27, 2026 | 8.64 | 8.86 | 8.475 | 8.64 | 1.540M |
| Jul 24, 2026 | 8.66 | 8.705 | 8.43 | 8.505 | 1.166M |
| Jul 23, 2026 | 8.50 | 8.68 | 8.32 | 8.62 | 1.812M |
| Jul 22, 2026 | 8.84 | 8.89 | 8.58 | 8.585 | 1.866M |
| Jul 21, 2026 | 8.70 | 9.135 | 8.67 | 8.93 | 1.585M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| EyePoint, Inc. | 4.87 |
| LENZ Therapeutics, Inc. | 4.59 |
| Merck & Co., Inc. | 150.66 |
| Theravance Biopharma, Inc. | 17.01 |
| ANI Pharmaceuticals, Inc. | 74.17 |
Price Related Metrics
| PS Ratio | 44.31 |
| PEG Ratio | -0.7199 |
| Price to Book Value | 4.552 |
| Earnings Yield | -13.11% |
| Market Cap | 2.367B |
| PEGY Ratio | -0.7199 |